Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms

International Journal of Radiation Oncology Biology Physics

Volumn 41, Issue 1, 1998, Pages 83-92

  Boersma, Liesbeth J ^a   Van Den Brink, Mandy ^a   Bruce, Allison M ^a   Shouman, Tarek ^a   Gras, Luuk ^a   Te Velde, Annet ^a   Lebesque, Joos V ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Conformal radiotherapy; Dose escalation; Dose volume histograms; Genitourinary complications; NTCPs; Prostate cancer; Rectum complications

Indexed keywords

ARTICLE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM HEMORRHAGE; SCORING SYSTEM; URETHRA STENOSIS;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY, COMPUTER-ASSISTED; RECTUM; URINARY BLADDER;

EID: 0032054090     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(98)00037-6     Document Type: Article

References (38)

1. Hanks G. E., Martz K. L., Diamond J. J. The effect of dose on local control of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 15:1988;1299-1305.
2. Leibel S. A., Heimann R., Kutcher G. J., Zelefsky M. J., Burman C. M., Melan E., Orazem J. P., Mohan R., LoSasso T. J., Lo Y.-C., Wiseberg J. A., Chapman D. S., Ling C. C., Fuks Z. Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate Preliminary results of a phase I dose-escalation study . Int. J. Radiat. Oncol. Biol. Phys. 28:1994;55-65.
3. Sandler H. M., McShan D. L., Lichter A. S. Potential improvement in the results of irradiation for prostate carcinoma using improved dose distribution. Int. J. Radiat. Oncol. Biol. Phys. 22:1991;361-367.
4. Hanks G. E., Lee W. R., Hanlon A. L., Kaplan E., Epstein B., Schultheiss T. Conformal technique dose escalation in prostate cancer Improved cancer control with higher doses in patients with pretreatment PSA >10 ngm/ml . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;861-868.
5. Perez C. A., Pilepich J. V., Zivnuska F. Tumor control in definitive irradiation of localized carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 12:1986;523-531.
6. Perez C. A., Pilepich J. V., Garcia D., Simpson J. R., Zivnuska F. Definitive radiation therapy in carcinoma of the prostate localized to the pelvis Experience at the Mallinckrodt Institute of Radiology. Management of clinically localized prostate cancer . NCI Monogr. 7:1988;85-94.
7. Sandler H. M., McLaughlin W., Kish K. E., Lichter A. S. Results of 3D conformal radiotherapy in the treatment of 707 patients with localized prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;141.
8. Benk V. A., Adams J. A., Shipley W. U., Urie M. M., McManus P. L., Efird J. T., Willett C. G., Goitein M. Late rectal bleeding following combined X-ray and proton high dose irradiation for patients with stages T3-T4 prostate carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 26:1993;551-557.
9. Kutcher G. J., Leibel S. A., Ling C. C., Zelefsky M., Fuks Z. New wine in an old bottle? Dose escalation under dose-volume constraints A model of conformal therapy of the prostate . Int. J. Radiat. Oncol. Biol. Phys. 35:1996;415-416.
10. Lee W. R., Hanks G. E., Hanlon A. L., Schultheiss T. E., Hunt M. A. Lateral shielding reduces rectal morbidity following high dose three-dimensional conformal radiotherapy for clinically localized prostate cancer: Further evidence for a significant dose effect. Int. J. Radiat. Oncol. Biol. Phys. 35:1996;251-257.
11. Sandler H. M., McLaughlin W., Ten Haken R. K., Addison H., Forman J., Lichter A. Three dimensional conformal radiotherapy for the treatment of prostate cancer Low risk of chronic rectal morbidity observed in a large series of patients . Int. J. Radiat. Oncol. Biol. Phys. 33:1995;797-801.
12. Schultheiss T. E., Hanks G. E., Hunt M. A., Lee R. Incidence of and factors related to late complications in conformal and conventional radiation treatment of cancer of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 32:1995;643-649.
13. Shipley W. U., Verhey L. J., Munzenrider J. E., Suit H. D., Urie M. M., McManus P. L., Young R. H., Shipley J. W., Zietman A. L., Biggs P. J., Heney N. M., Goitein M. Advanced prostate cancer The results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone . Int. J. Radiat. Oncol. Biol. Phys. 32:1995;3-12.
14. Smit W. G. J. M., Helle P. A., van Putten W. L. J., Wijnmalen A. J., Seldenrath J. J., van der Werf-Messing B. H. P. Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relations to rectal dose. Int. J. Radiat. Oncol. Biol. Phys. 18:1990;23-29.
15. Hartford A. C., Niemierko A., Adams J. A., Urie M. M., Shipley W. U. Conformal irradiation of the prostate Estimating long-term rectal bleeding risk using dose volume histograms . Int. J. Radiat. Oncol. Biol. Phys. 36:1996;721-730.
16. Leibel S. A., Zelefsky M. J., Kutcher G. J., Burman C. M., Kelson S. M., Fuks Z. Three-dimensional conformal radiation therapy in localized carcinoma of the prostate Interim report of a phase I dose-escalation study . J. Urol. 152:1994;1792-1798.
17. Marks L. B., Carroll P. R., Dugan T. C., Anscher M. S. The response of urinary bladder, urethra, and ureter to radiation and chemotherapy. Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1257-1280.
18. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J. E., Shank B., Solin L. J., Wesson M. Tolerance of normal tissue to therapeutic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;109-122.
19. Kutcher G. J., Burman C. Calculation of complication probability factors for nonuniform normal tissue irradiation The effective volume method . Int. J. Radiat. Oncol. Biol. Phys. 16:1989;1623-1630.
20. Lyman J. T. Complication probability as assessed from dose-volume histograms. Radiat. Res. 104:1985;S13-S19.
21. Lyman J. T., Wolbarst A. B. Optimization of radiation therapy, III A method of assessing complication probabilities from dose-volume histograms . Int. J. Radiat. Oncol. Biol. Phys. 13:1987;103-109.
22. Lyman J. T., Wolbarst A. B. Optimization of radiation therapy, IV A dose-volume histogram reduction algorithm . Int. J. Radiat. Oncol. Biol. Phys. 13:1989;103-109.
23. Lebesque J. V., Keus R. The simultaneous boost technique; The concept of relatively normalized total dose. Radiother. Oncol. 22:1991;45-55.
24. Roach M. III. Letter to the editor. Re: The use of prostate specific antigen: Clinical use of stage and Gleason score to predict pathologic stage in men with localized prostate cancer. J. Urol. 150:1993;1923-1924.
25. Cox J., Stetz J., Pajak Th. F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for Cancer Research and treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31:1995;1341-1346.
26. Pavy J. J., Denekamp J., Letschert J., Littbrand B., Mornex F., Bernier J., Gonzalez-Gonzalez D., Horiot J.-C., Bolla M., Bartelink H. EORTC late effects working group. Radiother. Oncol. 35:1995;11-60.
27. Lebesque J. V., Bruce A. M., Kroes A. P. G, Touw A., Shouman T., van Herk M. Variation in volumes, dose-volume histograms, and estimated normal tissue complication probabilities of rectum and bladder during conformal radiotherapy of T3 prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1109-1119.
28. Burman C., Kutcher G. J., Emami B., Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int. J. Radiat. Oncol. Biol. Phys. 21:1991;123-135.
29. Hanlon A. L., Schultheiss T. E., Hunt M. A., Movsas B., Peter R. S., Hanks G. E. Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales. Int. J. Radiat. Oncol. Biol. Phys. 38:1997;59-63.
30. Perez C. A., Breaux S., Bedwinek J. M., Madoc-Jones H., Camel H. M., Purdy J. A., Walz B. J. Radiation therapy alone in the treatment of carcinoma of the uterine cervix. Cancer. 54:1984;235-246.
31. Schultheiss T. E., Lee R., Hunt M. A., Hanlon A. L., Peter R. S., Hanks G. E. Late GI and GU complications in the treatment of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 37:1997;3-11.
32. Soffen E. M., Hanks G. E., Chang Hwang C., Chu J. C. H. Conformal static field therapy for low volume grade prostate cancer with rigid immobilization. Int. J. Radiat. Oncol. Biol. Phys. 20:1991;141-146.
33. Soffen E. M., Hanks G. E., Hunt M. A., Epstein B. E. Conformal static field radiation therapy treatment of early prostate cancer vs. nonconformal techniques A reduction in acute morbidity . Int. J. Radiat. Oncol. Biol. Phys. 24:1992;485-488.
34. Oldham M., Webb S. The optimization and inherent limitations of 3D conformal radiotherapy treatment plans of the prostate. Br. J. Radiol. 68:1995;882-893.
35. Marsh L. H., Ten Haken R. K., Sandler H. M. A customized nonaxial external beam technique for treatment of prostate carcinomas. Med. Dosim. 17:1992;123-127.
36. Lu Y., Spelbring P., Song S., Vijakumar C., Pelizzari C., Chen G. T. Y. Dose-surface histograms as treatment planning tool for prostate conformal therapy. Med. Phys. 22:1995;279-284.
37. Lu Y., Song P. Y., Li S.-H., Spelbring D. R., Vijayakumar S., Haraf D. J., Chen G. T. Y. A method of analyzing rectal complications in prostate conformal radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 33:1995;1121-1125.
38. MacKay R. I., Hendry J. H., Moore C. J., Williams P. C., Read G. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br. J. Radiol. 70:1997;517-526.